Ardelyx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.About ARDX
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.
ARDX Key Statistics
Stock Snapshot
With a market cap of 1.79B, Ardelyx(ARDX) trades at $7.40. The stock has a price-to-earnings ratio of -26.71.
During the trading session on 2026-05-04, Ardelyx(ARDX) shares reached a daily high of $7.47 and a low of $6.93. At a current price of $7.40, the stock is +6.8% higher than the low and still -0.9% under the high.
Trading volume for Ardelyx(ARDX) stock has reached 8.1M, versus its average volume of 4.24M.
The stock's 52-week range extends from a low of $3.21 to a high of $8.40.
The stock's 52-week range extends from a low of $3.21 to a high of $8.40.
ARDX News
It's been a pretty great week for Ardelyx, Inc. ( ) shareholders, with its shares surging 15% to US$6.88 in the week since its latest quarterly results. Revenue...
Ardelyx (ARDX) just reported first quarter 2026 results, with revenue of US$94.47 million versus US$74.11 million a year earlier, a net loss of US$37.61 million...
Ardelyx Inc ((ARDX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerfu...
Analyst ratings
100%
of 10 ratingsMore ARDX News
Ardelyx, Inc. reported its first-quarter 2026 results, with revenue rising to US$94.47 million from US$74.11 million a year earlier and net loss narrowing to US...
Analyst Matthew Caufield from H.C. Wainwright reiterated a Buy rating on Ardelyx and keeping the price target at $18.00. Unlock hedge fund-level data and power...
Image source: The Motley Fool. Apr. 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Michael Raab Chief Commercial Officer — Eric Foster C...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Reports Q1 revenue $94.47M, consensus $92.61M. “In the first quarter of 2026, Ardelyx (ARDX) continued our strong commercial execution which coupled with our st...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.